O’Reilly Automotive Inc. announced a significant increase in its share repurchase authorization, adding an additional $2 billion, bringing the total program to $31.75 billion. This new authorization is effective for three years starting June 1, 2026, with repurchases to be made in the open market. The move signals management's confidence in the company's financial health and is expected to enhance shareholder value by potentially increasing earnings per share.

Self-storage assets in Chicago continue to attract significant capital due to their low delinquency rates and limited new supply, contrasting with other commercial real estate sectors. High property taxes and challenging development conditions in Cook County have inadvertently created a disciplined supply environment for self-storage, leading to robust rental rate increases. While pricing has adjusted from peak years, lenders and investors remain actively involved, focusing on stabilized assets and experienced ownership, with continued transaction activity expected as loan maturities approach.

Savant Capital LLC significantly reduced its stake in AMETEK, Inc. (NYSE:AME) by 65.8% in Q4, selling over 10,000 shares. Despite this, AMETEK reported stronger-than-expected quarterly results with EPS of $1.97 and revenue of $1.93 billion, and analysts maintain a "Moderate Buy" rating with an average price target of $252.33. The company also declared a quarterly dividend of $0.34 per share and several other institutional investors increased their positions in the stock.

Goldman Sachs has significantly increased its price target for NetApp (NTAP) to $200 from $127, while reiterating a "Buy" rating on the stock. This adjustment reflects a strong positive outlook for the company, following similar upgrades from other firms like Argus Research and Barclays. NetApp specializes in data management and storage equipment, with strong sales in products, support, and cloud services.

TD Cowen has initiated coverage of Odyssey Therapeutics Inc. with a "Buy" rating. This news follows a recent "Overweight" rating from JPMorgan and Odyssey Therapeutics' addition to the NASDAQ Composite Index in May. Odyssey Therapeutics is a clinical-stage biopharmaceutical company focused on developing treatments for inflammatory and autoimmune diseases.

Legal & General Group Plc has reported a $17.57 million stake in Conagra Brands, despite reducing its position by 9.1% in the fourth quarter. Conagra Brands (NYSE:CAG) is trading near its 52-week low, and analyst sentiment remains weak with a "Reduce" consensus rating and a target price of $15.47. The company recently declared a quarterly dividend of $0.35 per share, resulting in a high yield, and experienced mixed Q4 earnings results.

National Pension Service significantly reduced its stake in Church & Dwight Co., Inc. by 97.0% during the fourth quarter, selling 358,028 shares. Following this, their holdings in CHD were valued at $918,000. Other institutional investors showed mixed activity, with some increasing and others initiating positions in the company's stock.

Savant Capital LLC reduced its stake in Rockwell Automation (NYSE:ROK) by 48.2% during the fourth quarter, selling 2,876 shares and holding 3,097 shares valued at $1.205 million. Other hedge funds also adjusted their positions, while company insiders sold over 11,000 shares worth more than $5 million in the last ninety days. Rockwell Automation recently beat earnings estimates, reported a revenue increase, and announced a quarterly dividend of $1.38 per share.

Intech Investment Management LLC significantly increased its stake in Cavco Industries (NASDAQ:CVCO) by 58% in Q4, acquiring an additional 2,116 shares to bring its total holding to 5,766 shares valued at approximately $3.4 million. This move comes as Cavco Industries reported better-than-expected earnings of $5.42 per share, although revenue was slightly below estimates. Analysts currently have a "Moderate Buy" consensus rating for the stock, with an average target price of $550.00.

National Pension Service has increased its stake in Textron Inc. (NYSE:TXT) by 17.5%, purchasing an additional 14,701 shares, bringing its total holdings to 98,656 shares valued at $8.6 million. Other institutional investors also adjusted their positions in Textron, which currently has a "Hold" rating from analysts with a consensus price target of $101.18. Textron recently announced a quarterly dividend of $0.02 per share and reported strong Q1 earnings, beating analyst estimates.